Der MKG-Chirurg

, Volume 3, Issue 1, pp 25–29 | Cite as

Adjuvante Therapie bei Kopf-Hals-Tumoren

State of the Art
  • K. Schwenzer-Zimmerer
  • K. Kansy
  • H.-F. Zeilhofer
  • A. Zippelius
  • F. Zimmermann
Leitthema
First Online:

Zusammenfassung

Der vorliegende Artikel gibt einen Überblick über aktuelle Therapiekonzepte der Kopf-Hals-Onkologie, insbesondere im Hinblick auf adjuvante Therapieformen. Im Fokus stehen dabei aktuelle Studienergebnisse der Radio- und Chemotherapie und ihre Bedeutung für das chirurgische Vorgehen. Zusätzlich werden neue Therapieansätze und ihre klinische Relevanz dargestellt. Schließlich werden häufige Komplikationen der heutigen Therapieformen und des Krankheitsbildes beschrieben. Die Übersicht soll dem Leser die Komplexität des Krankheitsbildes näherbringen und ihm die Behandlung der Patienten im Rahmen einer individualisierten, interdisziplinären Therapie nach dem neuesten Stand der Wissenschaft ermöglichen.

Schlüsselwörter

Plattenepithelkarzinom Adjuvante Behandlung Strahlentherapie Chemotherapie Multimodale Behandlung 

Adjuvant therapy in head and neck cancer

State of the art

Abstract

This article gives an overview about current treatment concepts in head and neck oncology, especially concerning adjuvant treatment modalities. In this context, we discuss current study results in radiation and chemotherapy and their importance for surgical procedures. Additionally, we present new treatment concepts and their clinical relevance. Finally, frequent complications of modern treatment concepts are described. The goal is to familiarize the readers with the complexity of this disease and enable them to manage their patients in an optimal, individual and interdisciplinary treatment concept according to the latest scientific results.

Keywords

Squamous cell carcinoma Adjuvant therapy Radiation Chemotherapy Multimodal therapy 
This is a preview of subscription content, log in to check access.

Notes

Interessenkonflikt

Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98CrossRefPubMedGoogle Scholar
  2. 2.
    Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27:843–850CrossRefPubMedGoogle Scholar
  3. 3.
    Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. European Organization for Research and Treatment of Cancer Trial 22931. N Engl J Med 350(19):1945–1952CrossRefPubMedGoogle Scholar
  4. 4.
    Bier J, Howaldt HP, Pitz H (1992) 4th German-Austrian-Swiss Study Group therapy study. Prospective, randomized, clinical study of squamous cell cancer of the mouth: radical neck dissection versus conservative neck dissection. Fortschr Kiefer Gesichtschir 37:108–110PubMedGoogle Scholar
  5. 5.
    Bitter K (1972) Pharmacokinetic studies on the intra-arterial application of methotrexate in the maxillofacial region. Osterr Z Stomatol 69:262–269PubMedGoogle Scholar
  6. 6.
    Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578CrossRefPubMedGoogle Scholar
  7. 7.
    Brazilian Head and Neck Cancer Study Group (1998) Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 176(5):422–427CrossRefGoogle Scholar
  8. 8.
    Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944CrossRefPubMedGoogle Scholar
  9. 9.
    Crile G (1906) Excision of cancer of the head and neck. JAMA 47:1780–1788Google Scholar
  10. 10.
    Crile G (1987) Landmark article Dec 1, 1906: Excision of cancer of the head and neck. With special reference to the plan of dissection based on one hundred and thirty-two operations. JAMA 258:3286–3293CrossRefPubMedGoogle Scholar
  11. 11.
    Eckardt A, Rades D, Rudat V et al (2002) Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome. Mund Kiefer GesichtsChir 6:117–121CrossRefPubMedGoogle Scholar
  12. 12.
    Eckardt A, Wegener G, Karstens JH (2006) Präoperative Radio-Chemo-Therapie fortgeschrittener, resektabler Mundhöhlenkarzinome mit Cisplatin versus Paclitaxel/Carboplatin: Analyse zweier multimodaler Therapiekonzepte. Mund Kiefer GesichtsChir 10:30–36CrossRefPubMedGoogle Scholar
  13. 13.
    Frerich B, Pistner H, Howaldt HP (2009) Onkologische Leitlinien in der Mund-Kiefer-, Gesichtschirurgie. MKG Chir 2:93–98CrossRefGoogle Scholar
  14. 14.
    Henke M, Laszig R, Rübe C et al (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362:1255–1260CrossRefPubMedGoogle Scholar
  15. 15.
    Horneber MA, Bueschel G, Huber R et al (2008) Mistletoe therapy in oncology. Cochrane Database Syst Rev 2:CD003297PubMedGoogle Scholar
  16. 16.
    Kligerman J, Lima RA, Soares JR et al (1994) Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 168(5):391–394CrossRefPubMedGoogle Scholar
  17. 17.
    Laramore GE, Scott CB, al-Sarraf M et al (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23(4):705–713PubMedGoogle Scholar
  18. 18.
    Lee WR, Berkey B, Marcial V et al (1998) Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85–27. Int J Radiat Oncol Biol Phys 42(5):1069–1075PubMedGoogle Scholar
  19. 19.
    Machtay M, Pajak T, Suntharalingam M et al (2004) Definitive radiotherapy + Erythropoietin for squamous cell carcinoma of the head and neck: preliminary report of RTOG 99-03. Int J Radiat Oncol Biol Phys 60(1):132CrossRefGoogle Scholar
  20. 20.
    Majoufre C, Faucher A, Laroche C et al (1999) Supraomohyoid neck dissection in cancer of the oral cavity. Am J Surg 178(1):73–77CrossRefPubMedGoogle Scholar
  21. 21.
    Metelmann HR (2000) Chemotherapy and radiochemotherapy in tumors of the head-neck area. Mund Kiefer GesichtsChir 4 (Suppl 1):155–159CrossRefGoogle Scholar
  22. 22.
    Mohr C, Bohndorf W, Gremmel H et al (1992) [Preoperative radio-chemotherapy and radical operation of advanced mouth cancers – final results of a prospective therapy study of the German-Austrian-Swiss Study Group]. Fortschr Kiefer Gesichtschir 37:13–17PubMedGoogle Scholar
  23. 23.
    Mohr C, Bohndorf W, Carstens J et al (1994) Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advenced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up) Int J Oral Maxillofac Surg 23(3):140–148Google Scholar
  24. 24.
    Mueller A, Kuhnt T (2005) Postoperative Radiochemotherapie bei High-risk-HNO-Tumoren. Neue Ergebnisse der RTOG- und EORTC-Studien. Onkologie 11:105–106CrossRefGoogle Scholar
  25. 25.
    Ninck S, Reisser C, Dyckhoff G et al (2003) Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 1006(1) 34–44Google Scholar
  26. 26.
    Papachristofilou A, Ihrler S, Röper B et al (2007) Therapie und Nachsorge der plattenepithelialen Karzinome des Oro- und Hypopharynx. InFo Onkologie 10 129–139Google Scholar
  27. 27.
    Pignon JP, Maître A le, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14CrossRefPubMedGoogle Scholar
  28. 28.
    Pigorsch ST, Gosau M, Panzer M et al (2009)Tumoren der Mundhöhle und Lippen. In: Mast G (Hrsg) Kopf-Hals-Malignome: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Manual Tumorzentrum München. Zuckschwerdt, Germering, S 243–255Google Scholar
  29. 29.
    Pigorsch ST, Röper B, Wypior H, Zimmermann F (2009) Allgemeine Grundsätze der Strahlentherapie. In: Mast G (Hrsg) Kopf-Hals-Malignome: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Manual Tumorzentrum München. Zuckschwerdt, Germering, S 4:70–77Google Scholar
  30. 30.
    Posner MR, Hershock DM, Blajman CR et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357(17):1705–1715CrossRefPubMedGoogle Scholar
  31. 31.
    Rehrmann A (1951) Unterkieferresektion und Lymphknotenausräumung. Dtsch Zahnärztl Z 26:1173Google Scholar
  32. 32.
    Rehrmann A (1954) Die Resektion der Kiefer. Barth, LeipzigGoogle Scholar
  33. 33.
    Rehrmann A, Scheunemann H, Hausamen J (1968): Die Chirurgie des Unterkieferkarzinoms unter besonderer Berücksichtigung der Lymphknoten, In: Schuchardt K (Hrsg) Fortschritte der Kiefer- und Gesichtschirurgie. Thieme, Stuttgart, S 56–61Google Scholar
  34. 34.
    Schultze J, Schillmoller H, Roldan JC et al (2006) Preoperative radiochemotherapy for advanced oral cavity tumours: the Kiel DOSAK experience regarding curability and quality of life. Mund Kiefer GesichtsChir 10:249–257CrossRefPubMedGoogle Scholar
  35. 35.
    Siefert A, Pöllinger B, Papachristofilou A et al (2009) Kombinierte Radiochemotherapie. In: Mast G (Hrsg) Kopf-Hals-Malignome: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Manual Tumorzentrum München. Zuckschwerdt, Germering, S 4:84–87Google Scholar
  36. 36.
    Simon C, PK P (2008) Multimodale Therapiestrategien bei der Behandlung von Kopf- und Halstumoren. HNO 56:575–584CrossRefPubMedGoogle Scholar
  37. 37.
    Staar S, Rudat V, Stuetzer H et al (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy – results of a multicentric randomised German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50(5):1161–1171PubMedGoogle Scholar
  38. 38.
    Vermorken JB, Trigo J, Hitt R et al (2007) Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 25(16):2171–2177CrossRefPubMedGoogle Scholar
  39. 39.
    Yii NW, Patel SG, Rhys-Evans PH, Breach NM (1999) Management of the N0 neck in early cancer of the oral tongue. Clin Otolaryngol Allied Sci 24(1):75–79CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2010

Authors and Affiliations

  • K. Schwenzer-Zimmerer
    • 1
  • K. Kansy
    • 1
  • H.-F. Zeilhofer
    • 1
  • A. Zippelius
    • 2
  • F. Zimmermann
    • 3
  1. 1.Klinik für Kiefer- und GesichtschirurgieUniversitätsspital BaselBaselSchweiz
  2. 2.Klinik für OnkologieUniversitätsspital BaselBaselSchweiz
  3. 3.Institut für RadioonkologieUniversitätsspital BaselBaselSchweiz

Personalised recommendations